BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tyndall A. Successes and failures of stem cell transplantation in autoimmune diseases. Hematology Am Soc Hematol Educ Program. 2011;2011:280-284. [PMID: 22160046 DOI: 10.1182/asheducation-2011.1.280] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Shandil RK, Dhup S, Narayanan S, Mishra R. Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases. Stem Cells International 2022;2022:1-8. [DOI: 10.1155/2022/6379161] [Reference Citation Analysis]
2 Jones OY, Mccurdy D. Cell Based Treatment of Autoimmune Diseases in Children. Front Pediatr 2022;10:855260. [DOI: 10.3389/fped.2022.855260] [Reference Citation Analysis]
3 Gallo A, Cuscino N, Contino F, Bulati M, Pampalone M, Amico G, Zito G, Carcione C, Centi C, Bertani A, Conaldi PG, Miceli V. Changes in the Transcriptome Profiles of Human Amnion-Derived Mesenchymal Stromal/Stem Cells Induced by Three-Dimensional Culture: A Potential Priming Strategy to Improve Their Properties. Int J Mol Sci 2022;23:863. [PMID: 35055049 DOI: 10.3390/ijms23020863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhou T, Rong M, Wang Z, Chu H, Chen C, Zhang J, Tian Z. Conditioned medium derived from 3D tooth germs: A novel cocktail for stem cell priming and early in vivo pulp regeneration. Cell Prolif 2021;54:e13129. [PMID: 34585454 DOI: 10.1111/cpr.13129] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Seo E, Lee BH, Lee JH, Park YS, Im HJ, Lee J. Hematopoietic stem cell transplantation in an infant with dedicator of cytokinesis 8 (DOCK8) deficiency associated with systemic lupus erythematosus: A case report. Medicine (Baltimore) 2021;100:e20866. [PMID: 33787566 DOI: 10.1097/MD.0000000000020866] [Reference Citation Analysis]
6 Rodas G, Soler-Rich R, Rius-Tarruella J, Alomar X, Balius R, Orozco L, Masci L, Maffulli N. Effect of Autologous Expanded Bone Marrow Mesenchymal Stem Cells or Leukocyte-Poor Platelet-Rich Plasma in Chronic Patellar Tendinopathy (With Gap >3 mm): Preliminary Outcomes After 6 Months of a Double-Blind, Randomized, Prospective Study. Am J Sports Med 2021;49:1492-504. [PMID: 33783227 DOI: 10.1177/0363546521998725] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
7 Ramalingam S, Shah A. Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis. Curr Allergy Asthma Rep 2021;21:22. [PMID: 33759038 DOI: 10.1007/s11882-021-00996-y] [Reference Citation Analysis]
8 Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. Int J Mol Sci 2021;22:E763. [PMID: 33466583 DOI: 10.3390/ijms22020763] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 33.0] [Reference Citation Analysis]
9 Li Y, Ye Z, Yang W, Zhang Q, Zeng J. An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases. Stem Cells Int 2021;2021:8834590. [PMID: 33505474 DOI: 10.1155/2021/8834590] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wu W, Xiao ZX, Zeng D, Huang F, Wang J, Liu Y, Bellanti JA, Olsen N, Zheng SG. B7-H1 Promotes the Functional Effect of Human Gingiva-Derived Mesenchymal Stem Cells on Collagen-Induced Arthritis Murine Model. Mol Ther 2020;28:2417-29. [PMID: 32707035 DOI: 10.1016/j.ymthe.2020.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nakashima T, Liu T, Hu B, Wu Z, Ullenbruch M, Omori K, Ding L, Hattori N, Phan SH. Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow. Am J Respir Crit Care Med 2019;200:1032-44. [PMID: 31106564 DOI: 10.1164/rccm.201808-1560OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Kamaldinov T, Erndt-Marino J, Levin M, Kaplan DL, Hahn MS. Assessment of Enrichment of Human Mesenchymal Stem Cells Based on Plasma and Mitochondrial Membrane Potentials.Bioelectricity. 2020;2:21-32. [PMID: 32292894 DOI: 10.1089/bioe.2019.0024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Yin L, Yang Z, Wu Y, Denslin V, Yu CC, Tee CA, Lim CT, Han J, Lee EH. Label-free separation of mesenchymal stem cell subpopulations with distinct differentiation potencies and paracrine effects. Biomaterials 2020;240:119881. [PMID: 32092592 DOI: 10.1016/j.biomaterials.2020.119881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Chen G, Zhang Y, Yu S, Sun W, Miao D. Bmi1 Overexpression in Mesenchymal Stem Cells Exerts Antiaging and Antiosteoporosis Effects by Inactivating p16/p19 Signaling and Inhibiting Oxidative Stress. Stem Cells 2019;37:1200-11. [PMID: 30895687 DOI: 10.1002/stem.3007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
15 Rad F, Ghorbani M, Mohammadi Roushandeh A, Habibi Roudkenar M. Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles. Mol Biol Rep. 2019;46:1533-1549. [PMID: 30623280 DOI: 10.1007/s11033-019-04588-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
16 Goldberg AJ, Zaidi R, Brooking D, Kim L, Korda M, Masci L, Green R, O'Donnell P, Smith R. Autologous Stem Cells in Achilles Tendinopathy (ASCAT): protocol for a phase IIA, single-centre, proof-of-concept study. BMJ Open 2018;8:e021600. [PMID: 29764889 DOI: 10.1136/bmjopen-2018-021600] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Macgregor M, Williams R, Downes J, Bachhuka A, Vasilev K. The Role of Controlled Surface Topography and Chemistry on Mouse Embryonic Stem Cell Attachment, Growth and Self-Renewal. Materials (Basel) 2017;10:E1081. [PMID: 28906470 DOI: 10.3390/ma10091081] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
18 Jauregui-Amezaga A, Rovira M, Marín P, Salas A, Pinó-Donnay S, Feu F, Elizalde JI, Fernández-Avilés F, Martínez C, Gutiérrez G, Rosiñol L, Carreras E, Urbano A, Lozano M, Cid J, Suárez-Lledó M, Mensa J, Rimola J, Rodríguez S, Masamunt MC, Comas D, Ruíz I, Ramírez-Morros A, Gallego M, Ordás I, Panés J, Ricart E. Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease. Gut 2016;65:1456-62. [PMID: 26585938 DOI: 10.1136/gutjnl-2015-309836] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
19 Maria ATJ, Maumus M, Le Quellec A, Jorgensen C, Noël D, Guilpain P. Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. Clinic Rev Allerg Immunol 2017;52:234-59. [DOI: 10.1007/s12016-016-8552-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 8.7] [Reference Citation Analysis]
20 Jauregui-amezaga A, Rovira M, López A, Marín P, Rodriguez S, Rimola J, Ordás I, Alfaro I, Panés J, Ricart E. Long-lasting Remission Induced by Syngeneic Haematopoietic Stem Cell Transplantation in a Patient with Refractory Crohn’s Disease. ECCOJC 2016;10:1122-4. [DOI: 10.1093/ecco-jcc/jjw062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
21 Wong RS. Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications. Human Immunology 2015;76:781-8. [DOI: 10.1016/j.humimm.2015.09.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
22 Kyrcz-krzemień S, Helbig G, Torba K, Koclęga A, Krawczyk-kuliś M. Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis. Hematology 2015;21:42-5. [DOI: 10.1179/1607845415y.0000000049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
23 Ducret M, Fabre H, Degoul O, Atzeni G, McGuckin C, Forraz N, Alliot-Licht B, Mallein-Gerin F, Perrier-Groult E, Farges JC. Manufacturing of dental pulp cell-based products from human third molars: current strategies and future investigations. Front Physiol 2015;6:213. [PMID: 26300779 DOI: 10.3389/fphys.2015.00213] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
24 Klinker MW, Wei CH. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells 2015; 7(3): 556-567 [PMID: 25914763 DOI: 10.4252/wjsc.v7.i3.556] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 9.9] [Reference Citation Analysis]
25 Ikhapoh IA, Pelham CJ, Agrawal DK. Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells. Differentiation 2015;89:87-96. [PMID: 25913202 DOI: 10.1016/j.diff.2015.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
26 Hayes M, Masterson C, Devaney J, Barry F, Elliman S, O'Brien T, O'Toole D, Curley GF, Laffey JG. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat. Anesthesiology 2015;122:363-73. [PMID: 25490744 DOI: 10.1097/ALN.0000000000000545] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
27 Li H, Jiang Y, Jiang X, Guo X, Ning H, Li Y, Liao L, Yao H, Wang X, Liu Y, Zhang Y, Chen H, Mao N. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect. Stem Cells 2014;32:1890-903. [PMID: 24496849 DOI: 10.1002/stem.1656] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
28 Liang J, Sun L. Mesenchymal stem cells transplantation for systemic lupus erythematosus. Int J Rheum Dis 2015;18:164-71. [PMID: 25611801 DOI: 10.1111/1756-185X.12531] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
29 Li H, Jiang YM, Sun YF, Li P, Dang RJ, Ning HM, Li YH, Zhang YJ, Jiang XX, Guo XM, Wen N, Han Y, Mao N, Chen H, Zhang Y. CCR7 expressing mesenchymal stem cells potently inhibit graft-versus-host disease by spoiling the fourth supplemental Billingham's tenet. PLoS One 2014;9:e115720. [PMID: 25549354 DOI: 10.1371/journal.pone.0115720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
30 Ratliff ML, Ward JM, Merrill JT, James JA, Webb CF. Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells. J Immunol 2015;194:940-9. [PMID: 25535283 DOI: 10.4049/jimmunol.1401941] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
31 Sciascia S, Khamashta MA, D'Cruz DP. Targeted therapy in antiphospholipid syndrome. Curr Opin Rheumatol 2014;26:269-75. [PMID: 24646948 DOI: 10.1097/BOR.0000000000000051] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
32 Kim J, Lee YT, Oh K, Cho J, Lee D, Hwang Y. Paradoxical effects of human adipose tissue-derived mesenchymal stem cells on progression of experimental arthritis in SKG mice. Cellular Immunology 2014;292:94-101. [DOI: 10.1016/j.cellimm.2014.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
33 Nemeth K, Mezey E. Bone marrow stromal cells as immunomodulators. A primer for dermatologists. J Dermatol Sci 2015;77:11-20. [PMID: 25476233 DOI: 10.1016/j.jdermsci.2014.10.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
34 Sommer IE, van Bekkum DW, Klein H, Yolken R, de Witte L, Talamo G. Severe chronic psychosis after allogeneic SCT from a schizophrenic sibling. Bone Marrow Transplant 2015;50:153-4. [PMID: 25285805 DOI: 10.1038/bmt.2014.221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
35 Mikkers HM, Freund C, Mummery CL, Hoeben RC. Cell replacement therapies: is it time to reprogram? Hum Gene Ther 2014;25:866-74. [PMID: 25141889 DOI: 10.1089/hum.2014.097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Wen Y, Elliott MJ, Huang Y, Miller TO, Corbin DR, Hussain L, Ratajczak MZ, Fukui Y, Ildstad ST. DOCK2 Is Critical for CD8 + TCR Graft Facilitating Cells to Enhance Engraftment of Hematopoietic Stem and Progenitor Cells: DOCK2 Is Critical to FCs Function. Stem Cells 2014;32:2732-43. [DOI: 10.1002/stem.1780] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
37 Pacini S. Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs). Front Cell Dev Biol 2014;2:50. [PMID: 25364757 DOI: 10.3389/fcell.2014.00050] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
38 Lee R, Perry B, Heywood J, Reese C, Bonner M, Hatfield CM, Silver RM, Visconti RP, Hoffman S, Tourkina E. Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis. Front Pharmacol 2014;5:140. [PMID: 24966836 DOI: 10.3389/fphar.2014.00140] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
39 Kimbrel EA, Kouris NA, Yavanian GJ, Chu J, Qin Y, Chan A, Singh RP, McCurdy D, Gordon L, Levinson RD, Lanza R. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev 2014;23:1611-24. [PMID: 24650034 DOI: 10.1089/scd.2013.0554] [Cited by in Crossref: 104] [Cited by in F6Publishing: 105] [Article Influence: 13.0] [Reference Citation Analysis]
40 Peña E, Souza CA, Escuissato DL, Gomes MM, Allan D, Tay J, Dennie CJ. Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation: Practical Approach to Imaging Diagnosis. RadioGraphics 2014;34:663-83. [DOI: 10.1148/rg.343135080] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
41 Mastri M, Lin H, Lee T. Enhancing the efficacy of mesenchymal stem cell therapy. World J Stem Cells 2014; 6(2): 82-93 [PMID: 24772236 DOI: 10.4252/wjsc.v6.i2.82] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 8.3] [Reference Citation Analysis]
42 Martínez-Montiel Mdel P, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol 2014;20:1211-27. [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
43 Pietras EM, Lakshminarasimhan R, Techner JM, Fong S, Flach J, Binnewies M, Passegué E. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J Exp Med 2014;211:245-62. [PMID: 24493802 DOI: 10.1084/jem.20131043] [Cited by in Crossref: 151] [Cited by in F6Publishing: 155] [Article Influence: 18.9] [Reference Citation Analysis]
44 Liu YH, Chan J, Vaghjiani V, Murthi P, Manuelpillai U, Toh BH. Human amniotic epithelial cells suppress relapse of corticosteroid-remitted experimental autoimmune disease. Cytotherapy 2014;16:535-44. [PMID: 24411589 DOI: 10.1016/j.jcyt.2013.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
45 Fierabracci A, Del Fattore A, Luciano R, Muraca M, Teti A, Muraca M. Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles. Cell Transplant. 2015;24:133-149. [PMID: 24268069 DOI: 10.3727/096368913x675728] [Cited by in Crossref: 72] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
46 Jethwa H, Adami AA, Maher J. Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time? Clin Immunol. 2014;150:51-63. [PMID: 24333533 DOI: 10.1016/j.clim.2013.11.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
47 Gratwohl A, Baldomero H, Passweg J. Hematopoietic stem cell transplantation activity in Europe: . Current Opinion in Hematology 2013;20:485-93. [DOI: 10.1097/moh.0b013e328364f573] [Cited by in Crossref: 42] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
48 Scruggs BA, Semon JA, Zhang X, Zhang S, Bowles AC, Pandey AC, Imhof KM, Kalueff AV, Gimble JM, Bunnell BA. Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model. Stem Cells Transl Med 2013;2:797-807. [PMID: 24018793 DOI: 10.5966/sctm.2013-0026] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 6.2] [Reference Citation Analysis]
49 Pesmatzoglou M, Dimitriou H, Stiakaki E. Could mesenchymal stromal cells have a role in childhood autoimmune diseases? Immunol Invest 2013;42:639-56. [PMID: 24004061 DOI: 10.3109/08820139.2013.822393] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Kosmas C, Papachrysanthou T, Daladimos T, Athanasopoulos A, Tsavaris N, Vlachoyiannopoulos PG. Control of relapsed germ cell tumor and SLE nephritis by high-dose chemotherapy and autologous hematopoietic cell transplantation. Future Oncol 2013;9:1401-6. [PMID: 23980687 DOI: 10.2217/fon.13.70] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Rodrigues MC, Hamerschlak N, de Moraes DA, Simões BP, Rodrigues M, Ribeiro AA, Voltarelli JC. Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis. Rev Bras Hematol Hemoter 2013;35:134-43. [PMID: 23741192 DOI: 10.5581/1516-8484.20130035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
52 Mascarenhas S, Avalos B, Ardoin SP. An update on stem cell transplantation in autoimmune rheumatologic disorders. Curr Allergy Asthma Rep 2012;12:530-40. [PMID: 22956390 DOI: 10.1007/s11882-012-0298-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
53 Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Med 2013;11:95. [PMID: 23557013 DOI: 10.1186/1741-7015-11-95] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
54 Yan SX, Deng XM, Wei W. A big step forward in the treatment of refractory systemic lupus erythematosus: allogenic mesenchymal stem cell transplantation. Acta Pharmacol Sin 2013;34:453-4. [PMID: 23558796 DOI: 10.1038/aps.2013.33] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
55 Chen Y, Luo R, Xu Y, Cai X, Li W, Tan K, Huang J, Dai Y. Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine. Rheumatol Int 2013;33:2127-34. [PMID: 23430158 DOI: 10.1007/s00296-013-2704-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
56 Hawkey CJ. Stem cells as treatment in inflammatory bowel disease. Dig Dis 2012;30 Suppl 3:134-9. [PMID: 23295704 DOI: 10.1159/000342740] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
57 Lee T. Stem cell therapy independent of stemness. World J Stem Cells 2012; 4(12): 120-124 [PMID: 23516128 DOI: 10.4252/wjsc.v4.i12.120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
58 McMahan ZH, Hummers LK. Systemic sclerosis--challenges for clinical practice. Nat Rev Rheumatol 2013;9:90-100. [PMID: 23147899 DOI: 10.1038/nrrheum.2012.191] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
59 Martin I, Baldomero H, Bocelli-tyndall C, Passweg J, Saris D, Tyndall A. The Survey on Cellular and Engineered Tissue Therapies in Europe in 2010. Tissue Engineering Part A 2012;18:2268-79. [DOI: 10.1089/ten.tea.2012.0169] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
60 Bluestone JA, Bour-Jordan H. Current and future immunomodulation strategies to restore tolerance in autoimmune diseases. Cold Spring Harb Perspect Biol 2012;4:a007542. [PMID: 23125012 DOI: 10.1101/cshperspect.a007542] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
61 Hasselblatt P, Drognitz K, Potthoff K, Bertz H, Kruis W, Schmidt C, Stallmach A, Schmitt-Graeff A, Finke J, Kreisel W. Remission of refractory Crohn’s disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther. 2012;36:725-735. [PMID: 22937722 DOI: 10.1111/apt.12032] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
62 Mastri M, Shah Z, McLaughlin T, Greene CJ, Baum L, Suzuki G, Lee T. Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency. Am J Physiol Cell Physiol. 2012;303:C1021-C1033. [PMID: 22843797 DOI: 10.1152/ajpcell.00191.2012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
63 Orbay H, Tobita M, Mizuno H. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int. 2012;2012:461718. [PMID: 22666271 DOI: 10.1155/2012/461718] [Cited by in Crossref: 112] [Cited by in F6Publishing: 113] [Article Influence: 11.2] [Reference Citation Analysis]
64 Ilic D, Miere C, Lazic E. Umbilical cord blood stem cells: clinical trials in non-hematological disorders. British Medical Bulletin 2012;102:43-57. [DOI: 10.1093/bmb/lds008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]